| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer | SVP, Chief Medical Officer
2 companies
Attar Eyal C. is a Chief Medical Officer at Vor Biopharma Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 6 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | VOR Vor Biopharma Inc. | Chief Medical Officer | Sell | 2,227 | $1.42 | $3,162.34 | -1.7% | -87.1% | -52.0% | |
| Feb 10, 2025 | VOR Vor Biopharma Inc. | Chief Medical Officer | Sell | 2,554 | $1.37 | $3,498.98 | -1.9% | -87.5% | -49.7% | |
| Dec 27, 2024 | VOR Vor Biopharma Inc. | Chief Medical Officer | Sell | 10,334 | $1.25 | $12,917.50 | -11.3% | -39.7% | -42.0% | |
| Jun 3, 2024 | VOR Vor Biopharma Inc. | Chief Medical Officer | Sell | 14,645 | $1.39 | $20,356.55 | -13.2% | -41.7% | -84.5% | |
| Feb 28, 2022 | APRE Aprea Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 36,000 | $1.73 | $62,280.00 | -43.4% | -51.9% | -85.3% | |
| Sep 16, 2021 | APRE Aprea Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 15,968 | $4.68 | $74,730.24 | -16.1% | -28.9% | -82.4% | |
| Oct 7, 2019 | APRE Aprea Therapeutics, Inc. | SVP, Chief Medical Officer | Buy | 400 | $15.00 | $6,000.00 | New | - | - |